Suchergebnisse - (Person:"Moghimi, Setareh")

PubPharm (5)

1

Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents : A contemporary perspective of SAR and molecular docking studies

enthalten in: European journal of medicinal chemistry | 2023

von Moradi, M. | Mousavi, A. | Emamgholipour, Z. | +6

2

Drug design strategies for the treatment azole-resistant candidiasis

enthalten in: Expert opinion on drug discovery | 2022

von Moghimi, S. | Shafiei, M. | Foroumadi, A.

3

Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy

enthalten in: European journal of medicinal chemistry | 2021

von Ayati, A. | Moghimi, S. | Toolabi, M. | +1

4

A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy

enthalten in: Bioorganic chemistry | 2020

von Ayati, A. | Moghimi, S. | Salarinejad, S. | +3

5

Thiazole in the targeted anticancer drug discovery

enthalten in: Future medicinal chemistry | 2019

von Ayati, A. | Emami, S. | Moghimi, S. | +1

1
[1]